Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dermatomyositis associated with malignant melanoma—A marker of poor prognosis?  Meinhard Schiller, MD, Markus Böhm, MD, Peter Hensen, MD, Helge Riemann,

Similar presentations


Presentation on theme: "Dermatomyositis associated with malignant melanoma—A marker of poor prognosis?  Meinhard Schiller, MD, Markus Böhm, MD, Peter Hensen, MD, Helge Riemann,"— Presentation transcript:

1 Dermatomyositis associated with malignant melanoma—A marker of poor prognosis? 
Meinhard Schiller, MD, Markus Böhm, MD, Peter Hensen, MD, Helge Riemann, MD, Thomas A. Luger, MD, Dorothée Nashan, MD  Journal of the American Academy of Dermatology  Volume 54, Issue 2, Pages (February 2006) DOI: /j.jaad Copyright © 2006 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 A, Hyperkeratotic erythematous plaques of extensor surfaces of the fingers, with particular involvement of interphalangeal joints (Gottron's papules). B, Interface dermatitis with basal cell vacuolation and degeneration, perivascular lymphohistiocytic infiltrate. (Hematoxylin-eosin stain; original magnification ×200.) Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2006 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 Cumulative survival probabilities (calculated according to the Kaplan-Meier method) of patients with DM in association with MM stratified by stage of MM according to AJCC classification 2001 after restaging. Log-rank (Mantel-Cox) test was utilized to compare survival curves. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2006 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Dermatomyositis associated with malignant melanoma—A marker of poor prognosis?  Meinhard Schiller, MD, Markus Böhm, MD, Peter Hensen, MD, Helge Riemann,"

Similar presentations


Ads by Google